This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Massachusetts Institute of Technology. Active years: 2017-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2023
Title: Innovations of Rebecca L McClellan
Introduction
Rebecca L McClellan is a notable inventor based in Westwood, MA (US). She has made significant contributions to the field of chemistry, particularly in the development of novel compounds and their applications in medicine. With a total of 4 patents, her work has the potential to impact various therapeutic areas.
Latest Patents
Among her latest patents is the invention titled "Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereof." This patent provides compounds of Formula (I) and their salts, where each instance of R is independently optionally substituted C-Calkenyl. The patent also details compositions that include a compound of Formula (I) and an agent. Furthermore, it outlines methods and kits for delivering an agent to a subject or cell, aimed at treating and/or preventing a range of diseases. Additionally, it describes methods for preparing compounds of Formula (I) and their precursors.
Career Highlights
Rebecca is affiliated with the Massachusetts Institute of Technology, where she continues her research and development efforts. Her work is characterized by a strong focus on innovative chemical compounds that can lead to advancements in medical treatments.
Collaborations
Rebecca has collaborated with esteemed colleagues such as Daniel Griffith Anderson and Joseph R Dorkin. These partnerships have fostered a collaborative environment that enhances the research and development of her inventions.
Conclusion
Rebecca L McClellan's contributions to the field of chemistry through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
